Disease / condition

Cystic Fibrosis clinical trials

Free access to 1,078 studies·10+ countries·Updated daily140 recruiting
1,078
Total trials
10+
Countries
10+
Sponsors
140
Recruiting
By phase
N/A589
Phase 2140
Phase 3108
Phase 196
Phase 453
By status
Completed652
Recruiting140
Unknown92
Not yet recruit...71
Terminated59
Top countries
United States of America314
France92
United Kingdom76
Australia54
Canada33
Top sponsors
Vertex Pharmaceuti...156
Assistance Publiqu...22
Hospices Civils de...20
National Jewish He...16
University of Alab...16
Recent trials
Latest clinical trials for Cystic Fibrosis
2016-004318-82
A study comparing Tobramycin Inhalation Powder (TIP) administered once daily continuously versus TIP administered BID in 28 day on / 28 day off cycles for the treatment of pulmonary Pseudomonas aeruginosa in patients with cystic fibrosis
Novartis Pharmaceuticals Corpo...
2015-003537-99
A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis
F. Hoffmann-La Roche AG
2023-000946-41
A Study of the effects of Lumacaftor/Ivacaftor Treatment in Subjects
Vertex Pharmaceuticals Incorpo...
2017-001078-41
A study in people with cystic fibrosis (a rare pulmonary disease) to assess the pharmacokinetics and safety of a combination of two experimental drugs"
Vertex Pharmaceuticals Incorpo...
2019-002189-11
A Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Vertex Pharmaceuticals Incorpo...
2017-001309-34
Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease
Vertex Pharmaceuticals Incorpo...
2009-010261-23
Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older Homozygous for the F508del-CFTR Mutation
Vertex Pharmaceuticals Incorpo...
2016-001004-33
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
Vertex Pharmaceuticals Incorpo...
2017-000457-39
A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C->T or D1152H CFTR Mutation
Vertex Pharmaceuticals Incorpo...
NCT06356246Not yet recr...
Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
Assistance Publique - Hôpitaux...France
NCT06371261Recruiting
Pathogenicity of Species of the Achromobacter Genus in Patients From Reunion Island With Cystic Fibrosis
Centre Hospitalier Universitai...Réunion
NCT06350461Completed
Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study
Nicole HamblettUnited States of America
NCT06350474Completed
Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study
Nicole HamblettUnited States of America
NCT06350149Recruiting
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
Emory UniversityUnited States of America
NCT06327802Recruiting
Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment
Pole Sante Grace de DieuFrance
NCT06312787·Phase 1Recruitment ...
A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation
Vertex Pharmaceuticals Incorpo...United States of America
NCT06311292Recruiting
Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis
Daniel J. WeinerUnited States of America
NCT06364176·Phase 2Not yet recr...
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
University of Kansas Medical C...United States of America
NCT06302270Recruiting
CFTR Modulators in Pregnancy and Postpartum
Region StockholmSweden
NCT06313827Not yet recr...
e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
University of ValenciaSpain
About this record

Access comprehensive clinical trial information for Cystic Fibrosis through Pure Global AI's free database. This collection includes 1,078 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 140 trials are actively recruiting participants.

Research for Cystic Fibrosis is being conducted in United States of America, France, United Kingdom and 7+ other countries. Leading sponsors include Vertex Pharmaceuticals Incorporated and Assistance Publique - Hôpitaux de Paris. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,078 clinical trials studying Cystic Fibrosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Vertex Pharmaceuticals Incorporated, Assistance Publique - Hôpitaux de Paris, Hospices Civils de Lyon, among others.